These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 18377610)

  • 21. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
    Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion.
    Hartmann A; Bröcker EB; Hamm H
    J Dtsch Dermatol Ges; 2008 May; 6(5):383-5. PubMed ID: 18042249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.
    Schallreuter KU; Krüger C; Würfel BA; Panske A; Wood JM
    Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy of a novel topical formulation for vitiligo: compared evaluation of different treatment modalities in 149 patients.
    Buggiani G; Tsampau D; Hercogovà J; Rossi R; Brazzini B; Lotti T
    Dermatol Ther; 2012; 25(5):472-6. PubMed ID: 23046028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study.
    Lahiri K; Malakar S; Sarma N; Banerjee U
    Int J Dermatol; 2006 Jun; 45(6):649-55. PubMed ID: 16796620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on skin repigmentation therapies in vitiligo.
    Falabella R; Barona MI
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
    Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
    Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo.
    Hui-Lan Y; Xiao-Yan H; Jian-Yong F; Zong-Rong L
    Pediatr Dermatol; 2009; 26(3):354-6. PubMed ID: 19706108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck.
    Sassi F; Cazzaniga S; Tessari G; Chatenoud L; Reseghetti A; Marchesi L; Girolomoni G; Naldi L
    Br J Dermatol; 2008 Nov; 159(5):1186-91. PubMed ID: 18717675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective analysis of pimecrolimus cream 1% for treatment of facial vitiligo.
    Mayoral FA; Vega JM; Stavisky H; McCormick CL; Parneix-Spake A
    J Drugs Dermatol; 2007 May; 6(5):517-21. PubMed ID: 17679186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical pimecrolimus: a new horizon for vitiligo treatment?
    Sendur N; Karaman G; Saniç N; Savk E
    J Dermatolog Treat; 2006; 17(6):338-42. PubMed ID: 17853306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of the therapeutic efficacy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream, and dermabrasion combined with topical placentrex gel in localized stable vitiligo.
    Sethi S; Mahajan BB; Gupta RR; Ohri A
    Int J Dermatol; 2007 Aug; 46(8):875-9. PubMed ID: 17651178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Camouflaging vitiligo using a spray tan.
    Steuer AB; Zampella JG
    Dermatol Online J; 2020 Jul; 26(7):. PubMed ID: 32898413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining the Absorption Spectrum of the Skin After Application of a Popular Sunless Tanner, Dihydroxyacetone, Using Re ectance Photospectrometry.
    Graves MS; Lloyd AA; Ross EV
    J Drugs Dermatol; 2016 Nov; 15(11):1459-1460. PubMed ID: 28095563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitiligo: new and emerging treatments.
    Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
    Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical melagenine for repigmentation in twenty-two child patients with vitiligo on the scalp.
    Xu AE; Wei XD
    Chin Med J (Engl); 2004 Feb; 117(2):199-201. PubMed ID: 14975202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topically administered fluorouracil in vitiligo.
    Tsuji T; Hamada T
    Arch Dermatol; 1983 Sep; 119(9):722-7. PubMed ID: 6614958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo.
    Sanclemente G; Garcia JJ; Zuleta JJ; Diehl C; Correa C; Falabella R
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1359-64. PubMed ID: 18624857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.